Drug intelligence / Profile preview

Pueraria thomsonii

Development stage
Unknown
Modality
Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration
Oral, Topical
01

Overview

Pueraria thomsonii is a species of the Pueraria genus, which is primarily used in traditional Chinese medicine and as an edible food source. It's closely related to Pueraria lobata (kudzu), but has distinct chemical compositions and uses. ## Botanical and Medicinal Profile Pueraria thomsonii is rich in bioactive compounds, particularly flavonoids and isoflavonoids. Compared to Pueraria lobata, it contains higher starch content but lower levels of soluble dietary fiber, insoluble dietary fiber, and crude protein[2][6]. This composition makes it better suited as an edible food, while P. lobata is more appropriate for medicinal applications[2]. The root of Pueraria thomsonii is used in herbal products, similar to other Pueraria species[7]. It contains various bioactive compounds including puerarin, daidzein, genistein, quercetin, and other flavonoids that contribute to its pharmacological properties. ## Traditional Uses Pueraria species have been used in traditional Chinese medicine for centuries. They are employed to treat various conditions including: - Cardiovascular and cerebrovascular diseases - High cholesterol (hypolipidemia) - High blood sugar (hyperglycemia) - High blood pressure - Cancer (inhibiting cancer cell activity) - Improving brain blood flow and oxygen supply[2][6] ## Pharmacological Properties While many studies focus on Pueraria species collectively, specific research on P. thomsonii indicates it has potential applications in: - Antioxidant activity - Metabolic regulation - Nutritional supplementation The root is available in various commercial forms including capsules, tablets, creams, gels, and soaps[5]. ## Safety Considerations As with other Pueraria species, P. thomsonii should be used with caution due to its phytoestrogen-like effects. It may interact with: - Estrogen medications - Blood-clotting medications - Methotrexate - Tamoxifen - Hepatotoxic drugs - Caffeine[3][5] It should be avoided during pregnancy and lactation due to lack of clinical data and its phytoestrogen activity[5].

Other names
Pueraria montana var. thomsoniiFengePuerariae Thomsonii RadixPueraria thomsoni
02

Targets

ESR2 (ERβ)ESR1 (ERα)

Beyond the preview

Go deeper on Pueraria thomsonii.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pueraria thomsonii.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call